Stockreport

Beam Therapeutics: Base Editing Leader With Major Catalyst Next Year [Seeking Alpha]

Beam Therapeutics Inc.  (BEAM) 
PDF asbeI covered Beam Therapeutics (NASDAQ:BEAMCo-foundedby David Liu, the Broad Institute and Harvard biochemist who also founded Editas, Beam is the leading developer of [Read more]